TKNO (Alpha Teknova) Marketable Securities: $11.43 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TKNO Alpha Teknova Inc TKNO
61 GF Score
Price $6.92
GF Value $4.45
Valuation Significantly Overvalued
! 5 Warning Signs
View Full Analysis

What is Alpha Teknova Marketable Securities?

Alpha Teknova TKNO -4.22% 61 Marketable Securities is $11.43 Mil as of Jun. 2026. GuruFocus rates TKNO with a GF Score™ of 61/100 and a GF Value™ of $4.45 (Significantly Overvalued). The stock has 5 warning signs investors should review.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Alpha Teknova's Marketable Securities for the quarter that ended in Jun. 2026 was $11.43 Mil.

Alpha Teknova's annual Marketable Securities increased from Dec. 2023 ($0.00 Mil) to Dec. 2024 ($26.69 Mil) but then declined from Dec. 2024 ($26.69 Mil) to Dec. 2025 ($15.43 Mil).

Alpha Teknova  (NAS:TKNO) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Alpha Teknova Marketable Securities Related Terms

Alpha Teknova Marketable Securities Historical Data

* Premium members only.

The historical data trend for Alpha Teknova's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Alpha Teknova Marketable Securities Chart

Alpha Teknova Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Marketable Securities
Get a 7-Day Free Trial 0.00 0.00 0.00 26.69 15.43

Alpha Teknova Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 20.72 18.91 15.43 13.48 11.43
TKNO
61GF Score
Alpha Teknova Inc TKNO
Marketable Securities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Alpha Teknova Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of $11.43 Mil mean?
Alpha Teknova (TKNO) has a Marketable Securities of $11.43 Mil as of Jun. 2026. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Alpha Teknova and its competitors.
Is Alpha Teknova's Marketable Securities too high?
Alpha Teknova's current Marketable Securities is $11.43 Mil. Overall, Alpha Teknova has a GF Score™ of 61/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Alpha Teknova's Marketable Securities compare to NIKA and BIOA?
Alpha Teknova's Marketable Securities of $11.43 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Drug Manufacturers company?
A good Marketable Securities depends on the Drug Manufacturers industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Alpha Teknova and its competitors. Alpha Teknova's current Marketable Securities is $11.43 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alpha Teknova stock overvalued right now?
Based on GuruFocus' analysis, Alpha Teknova (TKNO) is currently considered Significantly Overvalued. The stock's GF Value™ is $4.45, compared to a current price of $6.92 — trading 55.5% above its estimated fair value. The current Marketable Securities is $11.43 Mil. Alpha Teknova's overall GF Score™ is 61/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For Alpha Teknova (TKNO), the current Marketable Securities is $11.43 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Alpha Teknova (TKNO) Overvalued in 2026?

Based on GuruFocus' analysis, Alpha Teknova stock appears to be overvalued. The current stock price of $6.92 is trading 55.5% above its estimated GF Value™ of $4.45. GuruFocus considers Alpha Teknova to be Significantly Overvalued.

Key valuation signals for TKNO:

  • Marketable Securities: $11.43 Mil
  • GF Value™: $4.45 vs. price of $6.92 (55.5% above fair value)
  • GF Score™: 61/100 with 5 warning signs

No single metric tells the full story. See the TKNO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Alpha Teknova Business Description

Address 2451 Bert Drive, Hollister, CA, USA, 95023
Alpha Teknova Inc is a producer of critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics. Its offer two primary product categories: Lab Essentials and Clinical Solutions. It derives key revenue from the United States. The company offers three primary product types: (i) pre-poured media plates for cell growth and cloning; (ii) liquid microbial culture media and supplements for cellular expansion; and (iii) molecular biology reagents for sample manipulation, resuspension, and purification.
61GF Score

Get the complete analysis for TKNO

Marketable Securities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$6.92
Price
$4.45
GF Value